MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42

Colorectal cancer (CRC) is the third most common cancer worldwide. Metastatic progression is a primary factor contributing to lethality of CRC patients. However, the molecular mechanisms forming early local invasion and distant metastatic colonies are still unclear and the present therapeutic approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong-Xia, Chen, Yan-Ru, Liu, Shan-Shan, Ye, Ya-Ping, Jiao, Hong-Li, Wang, Shu-Yang, Xiao, Zhi-Yuan, Wei, Wen-Ting, Qiu, Jun-Feng, Liang, Li, Liao, Wen-Ting, Ding, Yan-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356701/
https://www.ncbi.nlm.nih.gov/pubmed/27769041
http://dx.doi.org/10.18632/oncotarget.12704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356701/
https://www.ncbi.nlm.nih.gov/pubmed/27769041
http://dx.doi.org/10.18632/oncotarget.12704

Ejemplares similares